Equine iPS cells and their ability to enhance tendon regeneration in vivo
马 iPS 细胞及其增强体内肌腱再生的能力
基本信息
- 批准号:8654299
- 负责人:
- 金额:$ 12.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-01 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdultAftercareAlkaline PhosphataseAllogenicAnimalsAntibody FormationAutologousBiochemicalBiologicalBiological AssayBiologyCell LineCell TransplantationCell physiologyCellsChromosomesClinicalDermalDiseaseDoctor of PhilosophyDoxycyclineEnvironmentEquus caballusExhibitsFibroblastsFlexorFlow CytometryGene Expression ProfileGenerationsGeneticHaplotypesHistologyHumanImageImmuneImmune responseImmunohistochemistryImmunologyInfiltrationInflammatory ResponseInjection of therapeutic agentInjuryInvestigationKnowledgeLaboratoriesLaboratory ResearchLearningLentivirus VectorLesionLeukocytesMHC Class I GenesMagnetic Resonance ImagingMentorsMesenchymal Stem CellsMethodsMixed Lymphocyte Culture TestModelingMolecularMolecular ProfilingMorphologyMusOrthopedicsPathologicPhasePhase TransitionPluripotent Stem CellsPreparationPropertyQualifyingRecordsRegenerative MedicineResearchResearch PersonnelSample SizeScientistSerumSpecialty BoardsStagingStaining methodStainsStem cellsSurgeonSystemTechniquesTendinitisTendon structureTeratomaTestingTherapeuticTimeLineTissuesToll-like receptorsTrainingTraining ProgramsTransplantationUltrasonographyUniversitiesVeterinariansViralWorkc-myc Genescareercell typeclinically relevantcytokineexpectationfetalgraduate studentimmunogenicin vivoin vivo Modelin vivo regenerationinduced pluripotent stem cellinsightknowledge basemolecular markerregenerativerepairedresearch studyresponseskillsstem cell biologystem cell therapytissue regenerationtranscriptome sequencing
项目摘要
DESCRIPTION (provided by applicant): This application seeks support for a specialty board certified (ACVS) equine veterinarian to complete the final stages of preparation for her career as a translational clinical scientist in the fields of stem cell biology and regenerative medicine. Th applicant will work in the Cornell University induced Pluripotent Stem (iPS) Cell Core Laboratory under the guidance of the her mentor, Dr. Lisa A. Fortier, and collaborator, Dr. John C. Schimenti. Dr. Fortier is a scientist and large animal orthopedic surgeon who is well established in the fields of tendon repair and stem cell therapies. Dr. Schimenti is regarded as an expert in the fields of genetics and stem cell biology. Both have outstanding records for training graduate students and mentoring postdoctoral candidates and the overall research environment at Cornell is unique and eminently qualified to train translational scientists. The proposal is divide into two phases, a mentored phase and a transition phase into an independent research investigator. During Phase I, the applicant will complete her Ph.D. and seek to broaden her knowledge base and skill set to develop a deeper understanding of the basic biology of iPS cells, including their immunogenic and immunomodulatory properties compared to mesenchymal stem cells (MSCs). The applicant and her mentor have assembled a team of immunology collaborators, Drs. Douglas Antczak, Julia Felippe (Flaminio), and Cynthia Leifer, to advise the applicant during this mentored phase and help her learn the valuable immunology concepts and methods needed to complete these studies and understand their biological significance. In Phase II the applicant will apply the knowledge and skills learned in Phase I to complete a proof-of- principle in vivo study examining the early and late biological responses of diseased tendon to iPS cell and MSC treatment and the regenerative potential of iPS cells and MSCs for tendon repair. For these studies, we will use the well established equine model of tendonitis which has been extensively used by our research group. These experiments will test the hypothesis that iPS cells will have similar immunogenic and immunomodulatory properties as MSCs but superior regenerative potential because they are pluripotent stem cells whereas MSCs are not. This information is clinically important for determining which stem cell type should be applied therapeutically in the treatment of tendon diseases. The expectation of this proposal is that the applicant will gain the necessary laboratory research, scientific, and management skills necessary to establish a niche in the field of regenerative medicine as an independent clinician scientist in an academic environment.
描述(由申请人提供):本申请寻求对专业委员会认证(ACVS)马兽医的支持,以完成她作为干细胞生物学和再生医学领域的转化临床科学家职业生涯的最后阶段的准备。申请人将在导师Lisa A. Fortier博士和合作者John C. Schimenti博士的指导下在康奈尔大学诱导多能干(iPS)细胞核心实验室工作。 Fortier 博士是一位科学家和大型动物整形外科医生,在肌腱修复和干细胞治疗领域颇有建树。 Schimenti 博士被认为是遗传学和干细胞生物学领域的专家。两者在培养研究生和指导博士后候选人方面都有着出色的记录,康奈尔大学的整体研究环境是独一无二的,非常适合培养转化科学家。该提案分为两个阶段:指导阶段和成为独立研究调查员的过渡阶段。 在第一阶段,申请人将完成她的博士学位。并寻求扩大她的知识基础和技能,以更深入地了解 iPS 细胞的基础生物学,包括与间充质干细胞 (MSC) 相比,它们的免疫原性和免疫调节特性。申请人和她的导师组建了一个免疫学合作者团队,博士。 Douglas Antczak、Julia Felippe (Flaminio) 和 Cynthia Leifer 在指导阶段为申请人提供建议,帮助她学习完成这些研究所需的有价值的免疫学概念和方法,并了解其生物学意义。 在第二阶段,申请人将应用第一阶段学到的知识和技能来完成原理验证体内研究,检查患病肌腱对 iPS 细胞和 MSC 治疗的早期和晚期生物反应,以及 iPS 细胞和 MSC 的再生潜力。用于肌腱修复的 MSC。在这些研究中,我们将使用我们的研究小组广泛使用的成熟的马肌腱炎模型。这些实验将检验以下假设:iPS 细胞具有与 MSC 类似的免疫原性和免疫调节特性,但具有卓越的再生潜力,因为它们是多能干细胞,而 MSC 则不是。该信息对于确定哪种干细胞类型应应用于肌腱疾病的治疗具有重要的临床意义。 该提案的期望是申请人将获得必要的实验室研究、科学和管理技能,以在学术环境中作为独立的临床科学家在再生医学领域建立一个利基市场。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lauren Virginia Schnabel其他文献
Lauren Virginia Schnabel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lauren Virginia Schnabel', 18)}}的其他基金
Equine iPS cells and their ability to enhance tendon regeneration in vivo
马 iPS 细胞及其增强体内肌腱再生的能力
- 批准号:
8705834 - 财政年份:2012
- 资助金额:
$ 12.61万 - 项目类别:
Equine iPS cells and their ability to enhance tendon regeneration in vivo
马 iPS 细胞及其增强体内肌腱再生的能力
- 批准号:
8298839 - 财政年份:2012
- 资助金额:
$ 12.61万 - 项目类别:
Equine iPS cells and their ability to enhance tendon regeneration in vivo
马 iPS 细胞及其增强体内肌腱再生的能力
- 批准号:
8463124 - 财政年份:2012
- 资助金额:
$ 12.61万 - 项目类别:
相似国自然基金
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Preclinical Validation of Personalized Molecular Assays for Measurable Residual Disease Monitoring in Pediatric AML
用于儿科 AML 可测量残留疾病监测的个性化分子检测的临床前验证
- 批准号:
10643568 - 财政年份:2023
- 资助金额:
$ 12.61万 - 项目类别:
Optimizing the dose of tafenoquine for the radical cure of Plasmodium vivax malaria in Southeast Asia
优化他非诺喹的剂量以根治东南亚间日疟原虫疟疾
- 批准号:
10703688 - 财政年份:2023
- 资助金额:
$ 12.61万 - 项目类别:
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
- 批准号:
10706874 - 财政年份:2023
- 资助金额:
$ 12.61万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 12.61万 - 项目类别:
Novel behavioral screening tool for therapeutics against organophosphorus agents
用于有机磷药物治疗的新型行为筛选工具
- 批准号:
10631009 - 财政年份:2023
- 资助金额:
$ 12.61万 - 项目类别: